A recent study found that montelukast, an antileukotriene medication, demonstrated significant positive effects on remission maintenance in patients with ulcerative colitis undergoing corticosteroid tapering, compared to placebo. The findings suggest that montelukast could be a valuable addition to managing ulcerative colitis, especially during corticosteroid tapering, but the study acknowledges limitations.

Source: BMJ Open Gastroenterology